KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Cash & Current Investments (2016 - 2025)

Historic Cash & Current Investments for Charles River Laboratories International (CRL) over the last 17 years, with Q3 2025 value amounting to $207.1 million.

  • Charles River Laboratories International's Cash & Current Investments fell 146.26% to $207.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $207.1 million, marking a year-over-year decrease of 146.26%. This contributed to the annual value of $194.6 million for FY2024, which is 2968.7% down from last year.
  • Charles River Laboratories International's Cash & Current Investments amounted to $207.1 million in Q3 2025, which was down 146.26% from $182.8 million recorded in Q2 2025.
  • In the past 5 years, Charles River Laboratories International's Cash & Current Investments ranged from a high of $465.4 million in Q1 2021 and a low of $157.2 million during Q3 2023
  • For the 5-year period, Charles River Laboratories International's Cash & Current Investments averaged around $230.4 million, with its median value being $210.2 million (2024).
  • Its Cash & Current Investments has fluctuated over the past 5 years, first crashed by 4803.11% in 2022, then soared by 6223.22% in 2024.
  • Charles River Laboratories International's Cash & Current Investments (Quarter) stood at $241.2 million in 2021, then fell by 3.03% to $233.9 million in 2022, then rose by 18.32% to $276.8 million in 2023, then fell by 29.69% to $194.6 million in 2024, then grew by 6.42% to $207.1 million in 2025.
  • Its last three reported values are $207.1 million in Q3 2025, $182.8 million for Q2 2025, and $229.4 million during Q1 2025.